Better Therapeutics, Inc. (BTTX) Selling and Marketing Expense USD 2020 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Better Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to 2022.
  • Better Therapeutics, Inc. Selling and Marketing Expense for the quarter ending September 30, 2023 was $1.39 M, a 10.6% decline year-over-year.
  • Better Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending September 30, 2023 was $6.9 M, a 6.72% increase year-over-year.
  • Better Therapeutics, Inc. annual Selling and Marketing Expense for 2022 was $6.98 M, a 199% increase from 2021.
  • Better Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $2.34 M, a 981% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $6.98 M +$4.64 M +199% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $2.34 M +$2.12 M +981% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $216 K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.